Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LN-145 by Iovance Biotherapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
LN-145 is under clinical development by Iovance Biotherapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...
Lifileucel by Iovance Biotherapeutics for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval
Lifileucel is under clinical development by Iovance Biotherapeutics and currently in Phase II for Recurrent Head And Neck Squamous Cell...
Lifileucel by Iovance Biotherapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
Lifileucel is under clinical development by Iovance Biotherapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...
IOV-4001 by Iovance Biotherapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
IOV-4001 is under clinical development by Iovance Biotherapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...
IOV-4001 by Iovance Biotherapeutics for Metastatic Melanoma: Likelihood of Approval
IOV-4001 is under clinical development by Iovance Biotherapeutics and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase...
Aldesleukin by Iovance Biotherapeutics for Graft Versus Host Disease (GVHD): Likelihood of Approval
Aldesleukin is under clinical development by Iovance Biotherapeutics and currently in Phase II for Graft Versus Host Disease (GVHD). According...